In this issue:
MPNs in young patients
Health-related QOL changes with long-term eltrombopag in persistent/ chronic ITP
Caplacizumab for acquired TTP
Pre-emptive rituximab for preventing long-term relapses in immune-mediated TTP
VWF Tyr2561 allele: a gain-offunction variant that increases MI risk
Common conditions in hereditary haemochromatosis genetic variants
Long-term outcomes for patients discharged from hospital with moderate anaemia
Thrombopoietin level predicts response to eltrombopag/romiplostim in ITP
VTE-BLEED for predicting major bleeding and other events in practice
Acute PE: 30-day outcomes after inadequate anticoagulation
Please login below to download this issue (PDF)